Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human Alcoholics

Neuropsychopharmacology

Volumn 41, Issue 3, 2016, Pages 659-660

  Mann, Karl ^a   Hoffmann, Sabine ^a   Pawlak, Cornelius R ^a,b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FRESENIUS UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; CALCIUM; PLACEBO; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE;

ALCOHOLISM; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; DRINKING BEHAVIOR; DRUG MECHANISM; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; VALIDATION STUDY; ANALOGS AND DERIVATIVES; ANIMAL; MALE; METABOLISM;

ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; CALCIUM; HUMANS; MALE; TAURINE;

EID: 84953931985     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.175     Document Type: Letter

References (6)

1. Crabbe JC (2012). Translational behavior-genetic studies of alcohol: Are we there yet? Genes Brain Behav 11: 375-386.
2. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R et al (2003). Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind, placebocontrolled study. Arch Gen Psychiatry 60: 92-99.
3. Littleton J (1995). Acamprosate in alcohol dependence: How does it work? Addiction 90: 1179-1188.
4. Mann K, Leménager T, Hoffmann S, Reinhard I, Hermann D, Batra A et al (2012). The PREDICT Study Team. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol 18: 937-946.
5. Morse AC, Koob GF (2002). Intra-BNST Acamprosate Attenuates Withdrawal-induced Increases in Ethanol Consumption in Dependent Rats. Society for Neuroscience Abstracts, 2002, 28: Abstract# 783.4.
6. Spanagel R, Vengeliene V, Jandeleit B, Fischer WN, Grindstaff K, Zhang X et al (2014). Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology 39: 783-791.